Indian Journal of Sleep Medicine

Register      Login

VOLUME 3 , ISSUE 1 ( January-March, 2008 ) > List of Articles


Narcolepsy-Cataplexy: Advances, Treatment and Research

Christian Guilleminault, Nelly Huynh

Citation Information : Guilleminault C, Huynh N. Narcolepsy-Cataplexy: Advances, Treatment and Research. Indian Sleep Med 2008; 3 (1):1-4.

DOI: 10.5005/ijsm-3-1-1

License: NA

Published Online: 01-06-2018

Copyright Statement:  NA


PDF Share
  1. Mignot E, Lin L, Rogers W, Honda Y, Qiu X, Lin X, Okun M, Hohjoh H, Miki T, Hsu S, Leffell M, Grumet F, Fernandez- Vina M, Honda M, Risch N. Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am J Hum Genet 2001; 68(3): 686-689.
  2. Honda Y, Asake A, TanakaY, et al. Discrimination of narcolepsy by using genetic markers and HLA. Sleep Res 1983;12: (abstract) 254.
  3. Gélineau JB. De la narcolepsie. Gaz Hop (Paris) 1880;53: 626-628.
  4. Daniels L. Narcolepsy. Medicine 1934;13: 1-122.
  5. Mignot E, Lammers GJ, Ripley B, Okun M, Nevsimalova S, Overeem S, Vankova J, Black J, Harsh J, Bassetti C, Schrader H, Nishino S. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 2002; 59(10): 1553-1562.
  6. Vankova J, Stepanova I, Jech R, Elleder M, Ling L, Mignot E, Nishino S, Nevsimalova S. Sleep disturbances and hypocretin deficiency in Niemann-Pick disease type C. Sleep 2003; 26(4): 427-430.
  7. Kanbayashi T, Abe M, Fujimoto S, Miyachi T, Takahashi T, Yano T, Sawaishi Y, Arii J, Szilagyi G, Shimizu T. Hypocretin deficiency in niemann-pick type C with cataplexy. Neuropediatrics 2003; 34(1): 52-53.
  8. Schwartz WJ, Stakes JW, Hobson JA. Transient cataplexy after removal of a craniopharyngioma. Neurology 1984;34(10):1372-1375.
  9. Malik S, Boeve BF, Krahn LE, Silber MH. Narcolepsy associated with other central nervous system disorders. Neurology 2001;57(3):539-541.
  10. Arii J, Kanbayashi T, Tanabe Y, Ono J, Nishino S, Kohno Y. A hypersomnolent girl with decreased CSF hypocretin level after removal of a hypothalamic tumor. Neurology 2001;56(12):1775-1776.
  11. Marcus CL, Trescher WH, Halbower AC, Lutz J. Secondary narcolepsy in children with brain tumors. Sleep 2002;25(4):435-439.
  12. D'Cruz OF, Vaughn BV, Gold SH, Greenwood RS. Symptomatic cataplexy in pontomedullary lesions. Neurology 1994;44(11):2189-2191.
  13. Aldrich MS, Naylor MW. Narcolepsy associated with lesions of the diencephalon. Neurology 1989;39(11):1505-1508.
  14. Mignot E, Lin L, Finn L, Lopes C, Pluff K, Sundstrom ML, Young T. Correlates of sleep-onset REM periods during the Multiple Sleep Latency Test in community adults. Brain 2006;129(Pt 6):1609-1623.
  15. Huang YS, Tafti M, Guilleminault C. Daytime sleepiness with and without cataplexy in Chinese-Taiwanese patients. Sleep Med 2006;7(5):454-457.
  16. Pelin Z, Guilleminault C, Risch N, Grumet FC, Mignot E. HLA-DQB1*0602 homozygosity increases relative risk for narcolepsy but not disease severity in two ethnic groups. US Modafinil in Narcolepsy Multicenter Study Group. Tissue Antigens 1998;51(1):96-100.
  17. Kubota H, Kanbayashi T, Tanabe Y, Ito M, Takanashi J, Kohno Y, Shimizu T. Decreased cerebrospinal fluid hypocretin-1 levels near the onset of narcolepsy in 2 prepubertal children. Sleep 2003;26(5):555-557.
  18. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. US Modafinil in Narcolepsy Study Group. Ann Neurol 1998;43(1):88-97.
  19. Ivanenko A, Tauman R, Gozal D. Modafinil in the treatment of excessive daytime sleepiness in children. Sleep Med 2003;4(6):579-582.
  20. Broughton R, Mamelak M. The treatment of narcolepsycataplexy with nocturnal gamma-hydroxybutyrate. Can J Neurol Sci 1979;6(1):1-6.
  21. Mamelak M, Scharf MB, Woods M. Treatment of narcolepsy with gamma-hydroxybutyrate. A review of clinical and sleep laboratory findings. Sleep 1986;9(1 Pt 2):285-289.
  22. The US Xyrem multicenter group: A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy. Sleep 2002;25(1):42-49.
  23. Lecendreux M, Maret S, Bassetti C, Mouren MC, Tafti M. Clinical efficacy of high-dose intravenous immunoglobulins near the onset of narcolepsy in a 10-year-old boy. J Sleep Res 2003;12(4):347-348.
  24. Dauvilliers Y, Carlander B, Rivier F, Touchon J, Tafti M. Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onset. Ann Neurol 2004;56(6):905-908.
  25. Zuberi SM, Mignot E, Ling L, McArthur I. Variable response to intravenous immunoglobulin therapy in childhood narcolepsy. J Sleep Res 2004;13(suppl.1): (abstract) 828.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.